GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

61

Long-Term Venous Thromboembolism Risk in Microscopic Colitis

The long-term risk of venous thromboembolism (VTE) in individuals with microscopic colitis (MC) has been evaluated in a nationwide Swedish cohort study. Microscopic colitis is an inflammatory bowel...

62

Efficacy and Safety of Linaclotide vs Plecanatide for Chronic Idiopathic Constipation

Linaclotide and plecanatide are both guanylate cyclase-C (GC-C) agonists approved for the treatment of chronic idiopathic constipation (CIC) in adults. While both drugs share a similar mechanism of...

63

Study Maps Genes Tied to Targets in Irritable Bowel Syndrome

Yes, the study you are referring to provides groundbreaking insights into the genetic underpinnings of Irritable Bowel Syndrome (IBS) and identifies potential therapeutic targets. This large genome-wide association...

64

The Impact of Emulsifiers on GI Health

The impact of dietary emulsifiers on gastrointestinal (GI) health has become a growing concern, particularly as the consumption of ultraprocessed foods—where these additives are commonly found—has risen globally....

65

Cost-effectiveness of Lynch Syndrome Screening in Colorectal Cancer

The study you are referring to evaluates the cost-effectiveness of different Lynch syndrome (LS) screening strategies in patients newly diagnosed with colorectal cancer (CRC). Lynch syndrome is a...

66

Peyer’s Patch B Cells Drive Celiac Disease Autoimmunity

Yes, Peyer’s patch B cells play a critical role in driving celiac disease autoimmunity. Here is a detailed explanation based on the context provided: Role of Peyer’s Patches...

67

Targeting Irritable Bowel Syndrome Through Diet and Mechanism-Based Therapies: A Pathophysiological Approach

The approach to targeting Irritable Bowel Syndrome (IBS) through diet and mechanism-based therapies emphasizes addressing the underlying pathophysiological mechanisms rather than merely managing symptoms. IBS is recognized as...

68

Diagnostic accuracy of biomarkers for irritable bowel syndrome: a systematic review and meta-analysis

The systematic review and meta-analysis you are inquiring about focuses on evaluating the diagnostic accuracy of emerging biomarkers for irritable bowel syndrome (IBS). IBS is a common gastrointestinal...

69

Editorial: Diverticulitis – A neglected disease despite its clinical burden

The editorial titled "Diverticulitis – A neglected disease despite its clinical burden" sheds light on diverticulitis as a significant yet underappreciated gastrointestinal condition that imposes a substantial burden...

70

mt-sDNA is supior tool for CRC screening

Yes, multitarget stool DNA (mt-sDNA) is considered a superior tool for colorectal cancer (CRC) screening, especially for younger adults under 50, based on the findings of the study...

Previous
167813
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer